Literature DB >> 782399

Procainamide-induced systemic lupus erythematosus. Renal involvement with deposition of immune complexes.

T S Whittle, S K Ainsworth.   

Abstract

A 54-year-old man sustained an acute anterior myocardial infarction and was subsequently treated with procainamide hydrochloride for 5 1/2 months, resulting in development of a drug-induced systemic lupus erythematosus (SLE) syndrome with renal involvement. In over 60 reported cases of procainamide-induced SLE, clinical renal evaluation has led to the concept that renal involvement is a rarity in this disease. Direct immunofluorescence examination of necropsy kidney tissue revealed mesangial deposition of immunoproteins and C3 in a granular pattern characteristically seen in idiopathic SLE. Ultrastructural studies confirm mesangial deposition of immune complexes. The immunological and ultrastructural pattern of immune complex deposition in glomeruli suggests similar pathological mechanisms for glomerular injury in procainamide as seen in idiopathic SLE.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782399

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

1.  Low-dose procainamide: low risk of complications with long-term use.

Authors:  C van Pham; J Noguchi; F P Quismorio; L J Haywood
Journal:  J Natl Med Assoc       Date:  1983-07       Impact factor: 1.798

2.  Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.

Authors:  R A Asherson; J Zulman; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

Review 3.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.